| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |